M.D. Sass, LLC

Q3 2018 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Bobby Liu - Chief Operating Officer and General Counsel
Location
New York
Holdings as of
September 30, 2018
Value $
$758M
Num holdings
47
Date filed
1/30/2020, 01:59 PM
Form type
13F-HR/A-1 - Restatement
Description
All US holdings of this investor are reported in this report. Top holdings included SPY, NRG, NCLH, SABR, and PHG.
Previous filing
Q2 2018 - Jan 30, 2020
Next filing
Q4 2018 - Jan 30, 2020
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2018 Q3 - Restatement compared to 2018 Q2 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Bobby Liu Chief Operating Officer and General Counsel New York, New York 1/30/2020

Other Included Managers (2):

Num Name Location File Number
1 M.D. Sass Associates, Inc. New York, NY 028-12005
2 M.D. Sass, LLC New York, NY 028-16534